Showing 1671-1680 of 2774 results for "".
- Novaestiq’s Partner Croma-Pharma Submits Final Application for Hyaluronic Acid Dermal Fillerhttps://modernaesthetics.com/news/novaestiqs-partner-croma-pharma-submits-final-application-for-hyaluronic-acid-dermal-filler/2473657/Novaestiq Corp., an aesthetic company that focuses on delivering intelligent and innovative skin solutions to practices and patients, announced its partner Croma-Pharma GmbH finalized the submission of its premarket approval to the US Food and Drug Administration (FDA) for the saypha MagIQ hyalur
- Pre-Clinical Study for Regenerative Commercial-Sized Breast Implants Announcedhttps://modernaesthetics.com/news/pre-clinical-study-for-regenerative-commercial-sized-breast-implants-announced/2473655/The advancement of regenerative medicine continues to grow at a rapid pace. CollPlant Biotechnologies and Stratasys Ltd. announced the initiation of a pre-clinical study with 200cc commercial-sized regenerative implants printed on Stratasys Origin 3D printer. The collaboration is
- Crown Laboratories, Revance Announce Entry Into Merger Agreementhttps://modernaesthetics.com/news/crown-laboratories-revance-announce-entry-into-merger-agreement/2473649/Crown Laboratories, Inc., a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc., a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, announced a merger agreement pursuant to whic
- L’Oréal Eyes Aesthetics Market with Acquisition of Minority Stake in Galdermahttps://modernaesthetics.com/news/loreal-eyes-aesthetics-market-with-acquisition-of-galderma/2473646/Major beauty brand L’Oréal announced the acquisition of a 10% stake in Galderma, a Swiss pharmaceutical company. The two companies have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies, according to a press releas
- Signature Facial Experience from Luxury Australian Beauty Brand Now Available in NYChttps://modernaesthetics.com/news/signature-facial-experience-from-luxury-australian-beauty-brand-now-available-in-nyc/2473643/A popular signature facial experience from the Australian luxury beauty brand RATIONALE is now available in New York City. The company launched the RATIONALE Residency at the Equinox Hotel, and private in-home appointments by request, on August 1. Rationale is known for its luxuri
- Evolus Expands Global Footprint with Introduction of Treatment in Australiahttps://modernaesthetics.com/news/evolus-expands-global-footprint-with-introduction-of-treatment-in-australia/2473641/The performance beauty company, Evolus, has begun operations in Australia with the launch of Nuceiva, a prabotulinumtoxinA. Nuceiva is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabella lines in adul
- Allergen Aesthetics Brings Back JUVÉDERM® Dayhttps://modernaesthetics.com/news/allergen-aesthetics-brings-back-juvederm-day/2473639/Allergan Aesthetics announced the return of JUVÉDERM® Day on Wednesday, August 21. The event, held for the first time last year, features limited-time offers, savings, and exclusive deals through Allē, the Allergan Aesthetics loyalty rewards program.
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f
- Annual Business-Building Elite Retreat Set to Get Underway July 26-27https://modernaesthetics.com/news/annual-business-building-elite-retreat-set-to-get-underway-july-26-27/2473631/Revision Skincare is hosting its third annual Elite Retreat for 130 medical aesthetics partners. The invite-only retreat is slated for July 26 and 27 in Dallas, Texas and will feature a special guest, WNBA star and 4-time Olympic gold medal winner, philanthropist and former Wilhelmina model, Lisa
- Aesthetic Lasers and Energy Devices Market Size to Grow By $2.37Bhttps://modernaesthetics.com/news/aesthetic-lasers-and-energy-devices-market-size-to-grow-by-237b-5/2473637/The global aesthetics laser and energy devices market size is estimated to grow by $2.37 billion from 2024 to 2028. Technavio report the market will grow at a compound annual growth rate of almost 10.87% during the next four years. A key factor driving growth in the market is the